VCJ Fact Sheet for Ansbert Gadicke
Education: M.D. from J.W. Goethe University in Frankfurt.
Career Path: Dr. Ansbert Gadicke founded the MPM Group in 1992. He led MPM’s effort to build its Advisory and Investment Banking business from 1992 to 1996 and started its Asset Management business in 1996. Prior to founding MPM, Dr. Gadicke was employed by The Boston Consulting Group where he worked with management of pharmaceutical, biotechnology and health insurance companies. He has also held research positions at the Whitehead Institute at MIT, Harvard University and the German Cancer Research Center.
Venture focus: Biotech, Pharmacueticals
Investments: DoubleTwist, Centagenetix, Endeavor Pharmaceuticals, Genteric, Kourion, Mindset Biopharmaceuticals, Novirio Pharmaceuticals, Pharmasset, Omrix Biopharmaceuticals, ViaCell, BioMarin (NASDAQ: BMRN), Medigene AG (NMarkt: MDG), Transkaryotic Therapies Inc. (NASDAQ: TKTX), LXN Corp., Lexicon Pharmaceuticals and Transform.
Other Affiliations: Chairman of the Alumni Association of the Whitehead Institute. Member of Advisory Councils for Harvard Medical School, the Health Science and Technology Program of Harvard University and MIT.
Author: Published articles in leading scientific pubs like Nature and Cell.
Did You Know? Gadicke knows everything about Harley-Davidson motorcycles, but the newly sworn-in American citizen still doesn’t understand baseball.
Are we missing something?